·      PPAR gamma agonists: Rosiglitazone and Troglitazone [1, 9]

·      PPAR dual agonists: Muraglitazar [9, 10]

·      Insulin [14]

·      Chlorpropamide [15]

·      Corticosteroids [16, 17]

·      Phentolamine mesylate [18]

·      O-nitrotoluene sulfone [19]

·      HAART therapy [20, 21]